Dark

BIO
Bio-Rad Laboratories, Inc.Class A
stock NYSE

At Close

Oct 17, 2025 3:59:56 PM EDT

310.04USD-0.714%(-2.23)131,200

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-312.27)0

After-hours

Oct 17, 2025 4:34:30 PM EDT

313.00USD+0.955%(+2.96)100

OverviewOptionsHistoricalExchangesShortsNews

Jan 25, 2022

08:00AM EST Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022 Business Wire

Jan 24, 2022

09:47AM EST Overview Of Value Stocks In The Healthcare Sector Benzinga

Jan 5, 2022

04:15PM EST Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11 Business Wire

Dec 16, 2021

08:05AM EST Bio-Rad Appoints Simon May As EVP And Life Science Group President RTTNews

08:00AM EST Bio-Rad Appoints Simon May Executive Vice President and Life Science Group President Business Wire

Dec 13, 2021

08:35AM EST Albireo To Present Posters At NASPGHAN 2021 Dec. 13 And 15 Benzinga

Nov 1, 2021

10:55AM EDT A Look Into Healthcare Sector Value Stocks Benzinga

Oct 29, 2021

08:00AM EDT The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs Benzinga

Oct 28, 2021

04:45PM EDT Bio-Rad Laboratories Q3 EPS $3.71 Beats $2.44 Estimate, Sales $747.00M Beat $661.87M Estimate Benzinga

04:16PM EDT Bio-Rad Reports Third-Quarter 2021 Financial Results Business Wire

08:26AM EDT The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug Benzinga

04:08AM EDT Earnings Scheduled For October 28, 2021 Benzinga

Oct 27, 2021

11:55AM EDT Preview: Bio-Rad Laboratories's Earnings Benzinga

Oct 25, 2021

11:20AM EDT Overview Of Value Stocks In The Healthcare Sector Benzinga

Oct 24, 2021

11:45AM EDT The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More Benzinga

Oct 15, 2021

08:00AM EDT Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021 Business Wire

Oct 9, 2021

09:59AM EDT 15 Under 40, 14 Over 90: A Look At The Youngest And Oldest Members Of The Forbes 400 List Benzinga

Sep 27, 2021

10:20AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Sep 10, 2021

08:00AM EDT The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test Benzinga

Sep 8, 2021

07:32AM EDT The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod Benzinga

Sep 3, 2021

07:31AM EDT The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself Benzinga

Sep 2, 2021

08:20AM EDT The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab Benzinga

Sep 1, 2021

07:32AM EDT The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering Benzinga

Aug 31, 2021

08:15AM EDT The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical Benzinga

08:00AM EDT Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference Business Wire

Aug 26, 2021

08:09AM EDT The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO Benzinga

Aug 25, 2021

07:30AM EDT The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug Benzinga

Aug 24, 2021

08:09AM EDT The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal Benzinga

Aug 19, 2021

10:57AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 13, 2021

07:43AM EDT The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO Benzinga

Aug 6, 2021

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

Aug 5, 2021

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

Aug 4, 2021

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

Aug 3, 2021

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

Jul 30, 2021

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

07:30AM EDT Wells Fargo Maintains Overweight on Bio-Rad Laboratories, Raises Price Target to $930 Benzinga

Jul 29, 2021

05:14PM EDT Bio-Rad Laboratories Q2 EPS $3.54 Beats $2.66 Estimate, Sales $715.93M Beat $631.78M Estimate Benzinga

04:48PM EDT Recap: Bio-Rad Laboratories Q2 Earnings Benzinga

04:15PM EDT Bio-Rad Reports Second-Quarter 2021 Financial Results Business Wire

08:18AM EDT The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs Benzinga

04:23AM EDT Earnings Scheduled For July 29, 2021 Benzinga

Jul 28, 2021

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

Jul 27, 2021

12:28PM EDT 10x Genomics Entered Global Settlement And Patent Cross License With Bio-Rad Laboratories Resolving All Outstanding Litigation; Co. To Pay Bio-Rad $29.4M In Royalties And Interest Related To GEM Product Sales Benzinga

12:27PM EDT Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations Business Wire

06:30AM EDT Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes GlobeNewswire Inc

Jul 25, 2021

10:05AM EDT The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More Benzinga

Jul 14, 2021

04:15PM EDT Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021 Business Wire

Jul 8, 2021

07:45AM EDT The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test Benzinga

Jun 30, 2021

05:00PM EDT Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products Benzinga

Jun 21, 2021

08:56AM EDT Bio-Rad Laboratories Inc. (BIO) said that it has launched its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit, a tool used to detect SARS-CoV-2 in a community's wastewater. RTTNews

08:12AM EDT Bio-Rad Launches PREvalence DdPCR SARS-CoV-2 Wastewater Quantification Kit RTTNews

08:00AM EDT Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing Business Wire

Jun 14, 2021

09:57AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Jun 2, 2021

07:44AM EDT Royalty Pharma Announces $2.025B Funding Partnership With MorphoSys To Enable MorphoSys' Acquisition Of Constellation; Royalty To Acquire Rights To Receive Royalties On Multiple Products Benzinga

May 20, 2021

08:30AM EDT Bio-Rad to Participate at Jefferies Virtual Healthcare Conference Business Wire

May 13, 2021

01:41PM EDT 5 Value Stocks In The Healthcare Sector Benzinga

Apr 29, 2021

05:06PM EDT Bio-Rad Laboratories Q1 EPS $5.21 Beats $3.00 Estimate, Sales $726.80M Beat $660.98M Estimate Benzinga

04:15PM EDT Bio-Rad Reports First-Quarter 2021 Financial Results Business Wire

08:15AM EDT The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx Benzinga

04:10AM EDT Earnings Scheduled For April 29, 2021 Benzinga

Apr 28, 2021

11:05AM EDT A Preview Of Bio-Rad Laboratories's Earnings Benzinga

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 15, 2021

08:30AM EDT Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021 Business Wire

Apr 5, 2021

10:07AM EDT 5 Value Stocks In The Healthcare Sector Benzinga

Mar 5, 2021

04:16PM EST Bio-Rad to Participate in Barclays Global Healthcare Conference 2021 Business Wire

Feb 23, 2021

07:40AM EST Biolase Appoints John R. Beaver As President And CEO Benzinga

Feb 22, 2021

04:15PM EST Bio-Rad to Participate in Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Business Wire

Feb 16, 2021

06:31AM EST Biodesix To Provide Antigen And Droplet Digital PCR Testing For Chicago Public School Teachers And Staff Benzinga

Feb 15, 2021

10:44AM EST A Look Into Healthcare Sector Value Stocks Benzinga

Feb 12, 2021

09:49AM EST Citigroup Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $750 Benzinga

Feb 11, 2021

04:52PM EST Bio-Rad Laboratories: Q4 Earnings Insights Benzinga

04:21PM EST Bio-Rad Sees FY21 Adj. Currency-Neutral Sales Growth 4.5-5% Year Over Year Benzinga

04:20PM EST Bio-Rad Laboratories Q4 Adj. EPS $4.01 Beats $3.29 Estimate, Sales $757.90M Beat $686.80M Estimate Benzinga

04:20PM EST Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results Business Wire

03:51AM EST Earnings Scheduled For February 11, 2021 Benzinga

Feb 10, 2021

10:31AM EST Earnings Preview: Bio-Rad Laboratories Benzinga

Feb 8, 2021

09:51AM EST A Look Into Healthcare Sector Value Stocks Benzinga

Feb 5, 2021

12:39PM EST Jefferies Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $725 Benzinga

Feb 4, 2021

06:19AM EST Bio-Rad Laboratories Says Initiated Restructuring Plan; Estimates It will Incur $125M-$130M In Total Costs Benzinga

06:16AM EST Bio-Rad Laboratories Plans Restructuring That Will Eliminate Total Of 530 Positions RTTNews

Jan 25, 2021

04:15PM EST Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021 Business Wire

Jan 21, 2021

08:13AM EST Intra-Cellular Therapies Highlights CAPLYTA Open-Label Safety Switching Study In Patients With Schizophrenia Published In Journal, Schizophrenia Research Benzinga

Jan 8, 2021

08:30AM EST Bio-Rad to Participate in Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on January 11 Business Wire

Dec 21, 2020

09:54AM EST A Look Into Healthcare Sector Value Stocks Benzinga

Dec 17, 2020

05:26PM EST 12 Emerging Technologies To Watch In 2021 Benzinga

Dec 11, 2020

08:11AM EST The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Benzinga

Dec 10, 2020

05:33PM EST Bio-Rad Provides Outlook Through 2023 Business Wire

Nov 23, 2020

10:24AM EST 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Nov 10, 2020

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

Nov 6, 2020

07:47AM EST The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold Benzinga

Nov 5, 2020

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

Nov 4, 2020

08:21AM EST The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings Benzinga

Nov 3, 2020

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

Nov 2, 2020

09:10AM EST Stocks Trading Near 52-Week Highs Before Open On Monday, Nov. 2, 2020: BIO, CLGX, EIGI, DNKN, PSHG, MDLY, NIO Benzinga

Oct 29, 2020

05:06PM EDT Bio-Rad Sees FY 2020 Sales Up 5.9%-6.3% Benzinga

05:05PM EDT Bio-Rad Laboratories Q3 EPS $3.00 Beats $1.80 Estimate, Sales $647.26M Beat $570.58M Estimate Benzinga

04:59PM EDT Bio-Rad Laboratories: Q3 Earnings Insights Benzinga

04:16PM EDT Bio-Rad Reports Third-Quarter 2020 Financial Results Business Wire

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

04:08AM EDT Earnings Scheduled For October 29, 2020 Benzinga

Oct 25, 2020

02:29PM EDT IPO Outlook: Insurance Cos., Mortgage Providers, Leslie's Pool Supplies Highlight This Week's Offerings Benzinga

Oct 22, 2020

07:52AM EDT The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat Benzinga

Oct 21, 2020

08:04AM EDT The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings Benzinga

Oct 20, 2020

08:17AM EDT The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger Benzinga

Oct 19, 2020

08:30AM EDT Bio-Rad to Report Third-Quarter 2020 Financial Results, Thursday, October 29, 2020 Business Wire

Sep 21, 2020

09:56AM EDT A Look Into Healthcare Sector Value Stocks Benzinga

Aug 19, 2020

07:08AM EDT Pluristem Announces End Of Patient Enrollment In Phase I Hematology Study Benzinga

Aug 12, 2020

07:14AM EDT Biorad Partner, Biodesix, Reports Plans To Provide Coronavirus ddPCR Diagnostic Testing For Colorado State University, No Terms Disclosed Benzinga

07:11AM EDT Biodesix Plans To Provide Coronavirus ddPCR Diagnostic Testing For Colorado State University, No Terms Disclosed Benzinga

Aug 4, 2020

08:35AM EDT U.S. Court Of Appeals For Federal Circuit Affirms 10x Genomics Willfully Infringed Bio-Rad U.S. Patent RTTNews

08:32AM EDT Bio-Rad Labs Reports US Appeals Court Affirms 10x Genomics Willfully Infringed Bio-Rad Patent, Upholds Lower Courts Award Of Damages For $23.9M Benzinga

08:30AM EDT The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court's Award of Damages Business Wire

Jul 31, 2020

08:18AM EDT 10 Biggest Price Target Changes For Friday Benzinga

07:10AM EDT Citigroup Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $625 Benzinga

Jul 30, 2020

04:57PM EDT Bio-Rad Laboratories Q2 EPS $1.61 Beats $1.15 Estimate, Sales $536.90M Beat $503.82M Estimate Benzinga

04:15PM EDT Bio-Rad Reports Second-Quarter 2020 Financial Results Business Wire

04:06AM EDT Earnings Scheduled For July 30, 2020 Benzinga

Jul 15, 2020

08:01PM EDT Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020 Business Wire